Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice

Theoretically, the subunit herpes zoster vaccine Shingrix(TM) could be used as a varicella vaccine that avoids the risk of developing shingles from vaccination, but bedside mixing strategies and the limited supply of the adjuvant component QS21 have made its application economically impracticable. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Han, Wang, Yunfei, Luan, Ning, Liu, Cunbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064366/
https://www.ncbi.nlm.nih.gov/pubmed/33805880
http://dx.doi.org/10.3390/vaccines9040310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064366/
https://www.ncbi.nlm.nih.gov/pubmed/33805880
http://dx.doi.org/10.3390/vaccines9040310

Ejemplares similares